Lycopene plays an important role as an antioxidative and anticancer agent， and is an increasingly valuable commodity in the global market. Rhodobacter sphaeroides， a carotenogenic and phototrophic bacterium， is an efficient and practical host for carotenoid production. Herein， we explored the potential of metabolically engineered Rb. sphaeroides as a novel platform to produce lycopene. The basal lycopene-producing strain was generated by introducing an exogenous crtI from Rhodospirillum rubrum to replace the native crtI and deleting crtC in Rb. sphaeroides. Furthermore， knocking out zwf blocked the competitive pentose phosphate pathway and improved the lycopene content by 88%. Finally， the methylerythritol phosphate pathway was reinforced by integration of dxs combined with zwf deletion， which further increased the lycopene content. The final engineered strain produced lycopene to 10.32 mg/g dry cell weight. This study describes a new lycopene producer and provides insight into a photosynthetic bacterium as a host for lycopene biosynthesis.